Erectile Dysfunction Therapy in Special Populations and Applications: Coronary Artery Disease
- 1 December 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (12) , 62-66
- https://doi.org/10.1016/j.amjcard.2005.10.008
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sexual Activity in Patients With AnginaJAMA, 2003
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Prognostic Value of Coronary Vascular Endothelial DysfunctionCirculation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial FunctionCirculation, 2002
- Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery DiseaseCirculation, 2001
- Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable anginaJournal of the American College of Cardiology, 2000
- Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart DiseaseCirculation, 2000
- Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial DysfunctionCirculation, 2000
- Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart diseaseThe American Journal of Cardiology, 1999